Open AccessThe Role of Bevacizumab in the Treatment of Non‐Small Cell Lung Cancer: Current Indications and Future Developments
Author(s) -
Gridelli Cesare,
Maione Paolo,
Rossi Antonio,
De Marinis Filippo
Publication year - 2007
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.12-10-1183
Subject(s) - bevacizumab , medicine , clinical trial , lung cancer , oncology , medical physics , intensive care medicine , chemotherapy
Learning Objectives After completing this course, the reader will be able to: Describe the main clinical trials of bevacizumab combined with chemotherapy in the treatment of advanced NSCLC. Describe the main clinical trials of bevacizumab combined with other targeted therapies in the treatment of advanced NSCLC. Describe some ongoing trials of bevacizumab in the treatment of NSCLC and try to define future developments of bevacizumab in this clinical setting.Access and take the CME test online and receive 1 AMA PRA Category 1 Credit ™ at CME.TheOncologist.com